GPT Analysis

Empower Your Investments! Unleash the Potential with Smart Stock Analysis!

United States Hong Kong China Singapore Japan India
Sorting Arrows
Symbol
▲ ▼
Company Name Rating
▲ ▼
Recommendation
▲ ▼
Evaluation from GPT Action Time
▲ ▼
STNE StoneCo Ltd - Class A 50 Negative StoneCo Ltd. (STNE) is a technology company operating in the software infrastructure sector. The company provides financial technology solutions to merchants and integrated partners in Brazil. STNE has shown strong revenue growth of 37.8% and gross margins of 73.04%. However, the company's profit margins are low at 0.20%. STNE has a high beta of 2.22, indicating higher volatility compared to the market. The stock has a trailing P/E ratio of 1359.0 and a forward P/E ratio of 14.61, suggesting potential overvaluation. The company has a solid balance sheet with a total cash of $5.11 billion and total debt of $4.59 billion. STNE has a target mean price of $14.17, which is close to the current price. Considering the high valuation and low profit margins, it is recommended to approach STNE with caution.

2023-08-07 13:41:09
TALS Talaris Therapeutics Inc 50 Negative Talaris Therapeutics, Inc. (TALS) is a biotechnology company in the healthcare sector. The company has 84 full-time employees and operates in the field of biotechnology. TALS shows a strong overall risk profile with audit risk of 2, board risk of 6, compensation risk of 8, and shareholder rights risk of 8. TALS has a market capitalization of $136 million and a beta of 2.30, indicating higher volatility compared to the market. The stock has a 52-week range of $0.89 to $5.23. TALS has a forward P/E ratio of -9.21, which indicates negative earnings. The company reported a net loss of $78 million in the last fiscal year and has a trailing EPS of -1.96. TALS has a strong cash position with total cash of $165 million, providing some financial stability. However, the company has total debt of $1.27 million, which should be considered. Based on these factors, it is difficult to provide a clear recommendation. Further research is recommended before making any investment decision.

2023-07-11 01:57:01
TLGA TLG Acquisition One Corp - Class A 25 Negative TLG Acquisition One Corp. (TLGA) is a shell company in the financial services sector. The company's stock has been experiencing a decline, with a negative 52-week change of -14.52%. TLGA has a trailing P/E ratio of infinity, indicating negative earnings. The company has no profit margins and a decreasing trend in revenue. TLGA also has a negative return on assets and a high debt level. The stock has a low trading volume and a low institutional ownership percentage. Considering these factors, it is recommended to avoid investing in TLGA at this time.

2023-07-26 14:48:47
TMF Direxion Daily 20+ Year Treasury Bull 3X Shares 20 Negative TMF is an exchange-traded fund (ETF) that seeks to provide daily investment results, before fees and expenses, of 300% of the performance of the ICE U.S. Treasury 20+ Year Bond Index. It is designed for short-term trading and not suitable for long-term investments. TMF is a leveraged fund, which means it uses borrowed money to amplify its returns. This strategy can lead to higher volatility and increased risk. The fund has a negative year-to-date return of -24.05% and a three-year average return of -47.91%. The fund's price has been declining over the past year, with a 52-week high of $11.87 and a 52-week low of $5.56. Considering the high risk and negative performance, it is not recommended to invest in TMF for long-term investors.

2023-08-28 14:52:12
TOI Oncology Institute Inc (The) 35 Negative The Oncology Institute, Inc. (TOI) operates in the medical care facilities industry within the healthcare sector. The company has 750 full-time employees and a market capitalization of $70,212,336. TOI's financial indicators reveal a negative profit margin of -17.96% and negative trailing earnings per share of -$0.81. Moreover, the company has experienced a recent decline in revenue growth and operating margins. It currently has a high level of total debt, which is more than its total cash. The stock's price performance has been highly volatile with a 52-week range of $0.33 to $7.60. Considering all these factors, the overall assessment is negative.

2023-07-28 22:50:09
TSP TuSimple Holdings Inc - Class A 20 Negative TuSimple Holdings Inc. (TSP) is a trucking company operating in the industrials sector. With a market capitalization of $500 million, TSP has 1,500 full-time employees. The company's financial indicators show negative fundamentals with a trailing EPS of -1.69 and a negative profit margin. TSP's revenue growth is at 48.6%, but it operates at a loss with negative operating margins. The stock's 52-week high is $10.63, but it currently trades around $2.19. With an overall risk rating of 10, PEG ratio of -1.25, and a low target mean price of $3.65, TSP does not appear to be a favorable investment option at the moment.

2023-07-27 03:17:23
URTY ProShares UltraPro Russell2000 3x Shares 50 Negative ProShares UltraPro Russell2000 (URTY) is an exchange-traded fund (ETF) that seeks to provide a return of 3 times the daily performance of the Russell 2000 Index. It aims to generate magnified returns by using leveraged strategies but should be used with caution, as leveraged funds are designed for short-term trading and not for long-term investment. URTY has a relatively high beta of 3.15, indicating that it is more volatile than the overall market. The ETF's year-to-date return is 23.01%, suggesting positive performance so far this year. However, the five-year average return is -14.47%, indicating poor long-term performance. Considering the high volatility and leveraged nature of URTY, it may not be suitable for all investors and should only be considered by those who understand the risks involved and have a high tolerance for volatility.

2023-08-04 20:03:37
VERU Veru Inc 45 Negative Veru Inc. (VERU) is a biotechnology company operating in the healthcare sector. The company has 233 full-time employees and focuses on developing and commercializing innovative medicines and medical devices for urology and oncology. VERU's financial indicators show some concerning factors, such as negative trailing EPS and a high debt-to-equity ratio of 105.187. The company has experienced negative revenue growth and operating margins. Additionally, the stock price has significantly declined from its 52-week high of $24.55 to its current price of $1.115. The average volume has also decreased. However, VERU has a positive recommendation from analysts, with a mean recommendation of 'buy' and a target mean price of $4.0. The company has a decent amount of cash on hand and a reasonable price-to-sales ratio of 4.6746936. Considering the overall financial indicators and analyst recommendations, it is advisable to approach investing in VERU with caution.

2023-08-08 19:19:59
WATT Energous Corp 40 Negative Energous Corporation (WATT) operates in the technology sector, specifically in the scientific and technical instruments industry. The company has a market capitalization of $20.4 million and employs 43 full-time employees. WATT's stock price has shown significant volatility over the past year, with a 52-week low of $0.18 and a high of $1.567. As of the last fiscal year, WATT reported a net income of -$25.8 million and trailing earnings per share (EPS) of -$0.3. The company's financials indicate negative profitability, with no dividends issued. WATT's current price-to-book ratio is 0.953, suggesting the stock may be undervalued. It's important to note that WATT's financial indicators paint a mixed picture, indicating higher risk. Therefore, the sentiment towards investing in WATT is negative.

2023-07-28 22:49:23
XPER Xperi Inc 35 Negative Xperi Inc. (XPER) is a software application company operating in the technology sector. With a market capitalization of $563 million and an enterprise value of $553 million, XPER develops and licenses innovative technologies. However, XPER has been facing several challenges, including negative profit margins, low return on equity, and significant debt-to-equity ratio. Its trailing EPS stands at -17.67 and the forward EPS is 0.45. The stock has shown a 52-week change of -41.13%. XPER's financial indicators suggest a financially unstable position. Although the stock has a buy recommendation with a target mean price of $18.20, it is important to exercise caution due to the company's poor financial performance. Therefore, considering the risk factors associated with this investment, the sentiment for XPER is 'Negative' and its rating is 35 out of 100.

2023-08-02 16:28:52
A Agilent Technologies Inc 40 Negative A is a stock listed on the NYSE with a market capitalization of $31.74 billion. The stock has a 52-week high of $160.26 and a 52-week low of $96.80. The current price is $108.47, which is close to the 52-week low. The stock has a negative year change of -25.90%. The 200-day average is $125.72, indicating a downward trend. The stock's trading volume is relatively low, with an average of 1,970,256 shares traded over the past three months. Based on these indicators, the stock does not seem to be performing well and may not be a good investment option at the moment.

2023-11-13 02:35:51
AAC-WS Ares Acquisition Corporation - Warrants (01/01/9999) 0 Negative Based on the provided financial indicators, it appears that AAC-WS does not have sufficient data available for analysis. The trailingPegRatio is not provided, and the quoteType is listed as NONE. Without these key indicators, it is difficult to assess the investment potential of AAC-WS. It is recommended to gather more information on the stock or consult with a financial advisor before making any investment decisions.

2023-10-23 00:10:14
BKKT Bakkt Holdings Inc - Class A 40 Negative Bakkt Holdings, Inc. (BKKT) operates in the software infrastructure industry within the technology sector. With a market capitalization of $136 million, BKKT has 1,037 full-time employees. The company's financial indicators show a negative profit margin of -1.54% and a negative trailing EPS of -9.37. Additionally, BKKT has a high debt-to-equity ratio of 11.11, indicating a significant debt burden. The stock has experienced a 52-week change of -42.47%. Analysts have a mixed opinion on BKKT, with a mean recommendation of 'hold'. The target mean price is $1.37, which is lower than the current price of $1.49. Considering these factors, it is advisable to approach BKKT with caution and conduct further research before making any investment decisions.

2023-08-31 10:45:01
BLDP Ballard Power Systems Inc 50 Negative Ballard Power Systems Inc. (BLDP) is a Canadian company operating in the specialty industrial machinery sector. The company has a market capitalization of $1.29 billion and operates with 1,296 full-time employees. BLDP's financial indicators show a negative profit margin of -2.01% and a negative trailing EPS of -0.49. The company's revenue growth has been negative at -26.9% and its gross margins are also negative at -27.57%. BLDP's current price is $4.32, with a 52-week range of $3.9 to $8.2. The stock has a target mean price of $6.5, indicating potential upside. However, the recommendation mean is 'hold' with 24 analyst opinions. BLDP has a high beta of 1.83, indicating higher volatility. Considering the negative financial indicators and mixed analyst opinions, it is recommended to approach BLDP with caution.

2023-08-29 23:18:58
BTCS BTCS Inc 30 Negative BTCS Inc. is a financial services company operating in the capital markets sector. The company has a small team of 5 full-time employees and a market capitalization of $12,902,837. BTCS operates in the United States and is listed on the NCM exchange. The stock has a beta of 1.742136, indicating higher volatility compared to the market. The company's financial indicators show negative trailing EPS of -0.34 and forward EPS of -0.31. The price-to-sales ratio is 9.831849, which is relatively high. BTCS has a high short ratio of 1.15, indicating potential short-term volatility. The company has negative net income and negative profit margins. The stock has experienced a 25.2% decline in the past 52 weeks. Considering these factors, the sentiment for investing in BTCS is negative.

2023-10-11 20:40:23
DDL Dingdong (Cayman) Ltd 30 Negative Dingdong (Cayman) Limited (DDL) is a Chinese grocery store company operating in the Consumer Defensive sector. The company has a market capitalization of $421.83 million and operates with 3,363 full-time employees. DDL's stock price has experienced significant volatility, with a 52-week range of $1.60 to $6.90. The stock is currently trading at $1.95, which is near its 52-week low. DDL has a negative profit margin of -1.75% and a negative return on equity of -75.21%. The company's financials show a high debt-to-equity ratio of 977.25, indicating a significant reliance on debt financing. DDL's revenue growth has been negative at -27% and the company has reported negative earnings per share. Considering these factors, the sentiment for investing in DDL is negative.

2023-10-02 08:49:07
DOCN DigitalOcean Holdings Inc 50 Negative DigitalOcean Holdings, Inc. (DOCN) is a technology company operating in the Software—Infrastructure industry. With a market capitalization of $2.39 billion, DOCN provides cloud infrastructure solutions to developers, startups, and businesses. The company's financial indicators show a mixed performance. While DOCN has a negative profit margin and trailing EPS, it has a strong revenue growth rate of 26.8% and a healthy cash position of $550.5 million. The stock has a forward P/E ratio of 15.34, indicating a reasonable valuation. However, the stock has experienced a significant decline of 41.8% in the past year. Analyst opinions are divided, with a mean recommendation of 'hold'. Considering the mixed financials, recent stock performance, and analyst opinions, the sentiment for investing in DOCN is 'Negative'. The rating for DOCN is 50, indicating a neutral outlook.

2023-09-09 22:14:02
DXC DXC Technology Company 50 Negative DXC Technology Company (DXC) operates in the Information Technology Services sector, specifically in the Technology industry. With a market capitalization of $4.18 billion, DXC is a significant player in the sector. The company has a large workforce of 130,000 employees and operates in the United States. DXC's financial indicators show a negative profit margin of -4.47% and a negative trailing EPS of -2.73. However, the forward EPS estimate of 3.93 suggests potential future growth. DXC has a low price-to-sales ratio of 0.30, indicating an undervalued stock. The company's high debt-to-equity ratio of 152.26 raises concerns about its financial stability. Analyst opinions on DXC are mixed, with a mean recommendation of 'hold.' Considering the financial indicators and analyst opinions, it is advisable to approach DXC with caution.

2023-09-13 10:46:22
EEIQ EpicQuest Education Group International Ltd 30 Negative EpicQuest Education Group International Limited (EEIQ) operates in the Education & Training Services industry within the Consumer Defensive sector. The company has 58 full-time employees and a market capitalization of $12,527,775. EEIQ's stock price has a 52-week range of $0.8 to $3.63, with a current price of $1.07. The stock has a beta of 0.71562, indicating a moderate level of volatility compared to the overall market. The company's financial indicators show negative profit margins, negative trailing EPS, and negative forward EPS. EEIQ has a high debt-to-equity ratio of 10.988, which indicates a higher level of financial risk. The company's revenue growth has been negative at -15.6% and its operating margins are also negative. Considering these factors, the sentiment for investing in EEIQ is 'Negative'. The rating for this stock is 30, indicating a below-average investment opportunity.

2023-09-05 08:00:07
FGEN FibroGen Inc 20 Negative FibroGen, Inc. (FGEN) is a biotechnology company operating in the healthcare sector. The company has a negative profit margin and negative earnings per share, indicating financial difficulties. FGEN's stock price has experienced a significant decline over the past year, with a 52-week change of -93.5%. The company's financial indicators, such as return on assets and return on equity, are also negative, suggesting poor performance. Additionally, FGEN has a high level of debt compared to its total cash. Considering these factors, it is not recommended to invest in FGEN at this time.

2023-10-02 08:43:12